December 4th, 2014
No Evidence to Support Routine Use of Aspirin in Women for Primary Prevention
Larry Husten, PHD
Although once widely recommended, aspirin for primary prevention has lost favor in recent years, as the large number of bleeding complications appeared to offset the reduction in cardiovascular events. But at the same time evidence has emerged demonstrating the long-term effect of aspirin in preventing colorectal cancer, leading some to think that the risk-to-benefit equation […]
June 6th, 2011
Smoking Found to Be ‘Potent’ Risk Factor for Symptomatic PAD in Women
Larry Husten, PHD
The latest report on the 40,000 women enrolled in the Women’s Health Study provides further demonstration that smoking is a “potent” risk factor for symptomatic peripheral artery disease. The paper, by David Conen and colleagues, appears in the Annals of Internal Medicine. Here are the age-adjusted incidence rates per 1000 person-years of follow-up: never smoked: 0.12 former […]
May 24th, 2011
New-Onset AF Linked to Increase in Death and CV Events in Women
Larry Husten, PHD
In the Women’s Health Study, which followed nearly 35,000 women for more than 15 years, mortality was significantly higher in the 1011 women who developed AF than in the women who did not, according to a report by David Conen and colleagues published in JAMA. Here are the incidence rates (per 1000 person-years of follow-up) for […]
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?